314 related articles for article (PubMed ID: 30633947)
1. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.
Johnsen KB; Bak M; Melander F; Thomsen MS; Burkhart A; Kempen PJ; Andresen TL; Moos T
J Control Release; 2019 Feb; 295():237-249. PubMed ID: 30633947
[TBL] [Abstract][Full Text] [Related]
2. Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles.
Johnsen KB; Bak M; Kempen PJ; Melander F; Burkhart A; Thomsen MS; Nielsen MS; Moos T; Andresen TL
Theranostics; 2018; 8(12):3416-3436. PubMed ID: 29930740
[No Abstract] [Full Text] [Related]
3. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
Johnsen KB; Moos T
J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
[TBL] [Abstract][Full Text] [Related]
4. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.
Wiley DT; Webster P; Gale A; Davis ME
Proc Natl Acad Sci U S A; 2013 May; 110(21):8662-7. PubMed ID: 23650374
[TBL] [Abstract][Full Text] [Related]
5. Targeting the transferrin receptor for brain drug delivery.
Johnsen KB; Burkhart A; Thomsen LB; Andresen TL; Moos T
Prog Neurobiol; 2019 Oct; 181():101665. PubMed ID: 31376426
[TBL] [Abstract][Full Text] [Related]
6. Transferrin Receptor-Mediated Uptake at the Blood-Brain Barrier Is Not Impaired by Alzheimer's Disease Neuropathology.
Bourassa P; Alata W; Tremblay C; Paris-Robidas S; Calon F
Mol Pharm; 2019 Feb; 16(2):583-594. PubMed ID: 30609376
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
8. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
9. Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma.
Johnsen KB; Burkhart A; Melander F; Kempen PJ; Vejlebo JB; Siupka P; Nielsen MS; Andresen TL; Moos T
Sci Rep; 2017 Sep; 7(1):10396. PubMed ID: 28871203
[TBL] [Abstract][Full Text] [Related]
10. Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier.
Cabezón I; Manich G; Martín-Venegas R; Camins A; Pelegrí C; Vilaplana J
Mol Pharm; 2015 Nov; 12(11):4137-45. PubMed ID: 26440359
[TBL] [Abstract][Full Text] [Related]
11. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
12. Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers.
McQuaid C; Halsey A; Dubois M; Romero I; Male D
PLoS One; 2021; 16(6):e0252341. PubMed ID: 34086733
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates.
Yu YJ; Atwal JK; Zhang Y; Tong RK; Wildsmith KR; Tan C; Bien-Ly N; Hersom M; Maloney JA; Meilandt WJ; Bumbaca D; Gadkar K; Hoyte K; Luk W; Lu Y; Ernst JA; Scearce-Levie K; Couch JA; Dennis MS; Watts RJ
Sci Transl Med; 2014 Nov; 6(261):261ra154. PubMed ID: 25378646
[TBL] [Abstract][Full Text] [Related]
14. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
Gosk S; Vermehren C; Storm G; Moos T
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
[TBL] [Abstract][Full Text] [Related]
15. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
17. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
[TBL] [Abstract][Full Text] [Related]
18. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
19. ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Pharm Res; 2019 Sep; 36(11):161. PubMed ID: 31529284
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
Pardridge WM
Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]